National Institute of Neurological Disorders and Stroke; Notice of Closed Meetings, 52915-52916 [2021-20580]
Download as PDF
<![CDATA[
52915
Federal Register / Vol. 86, No. 182 / Thursday, September 23, 2021 / Notices
TOTAL ESTIMATED ANNUALIZED BURDEN HOURS
SHIP COVID–19 Testing and
Mitigation Data Reporting.
Total ...................................
Number of responses per
respondent
1,540: Number of unique organizations funded through the
program.
6: Reported on a quarterly
basis during the 18 month
program or the end of the
public health emergency
(whichever is first).
9,240
.25
1,540 ........................................
...................................................
9,240
........................
HRSA specifically requests comments
on (1) the necessity and utility of the
proposed information collection for the
proper performance of the agency’s
functions, (2) the accuracy of the
estimated burden, (3) ways to enhance
the quality, utility, and clarity of the
information to be collected, and (4) the
use of automated collection techniques
or other forms of information
technology to minimize the information
collection burden.
Maria G. Button,
Director, Executive Secretariat.
Total
responses
Contact Person: Karen Nieves-Lugo,
M.P.H., Ph.D., Scientific Review Officer,
Office of Extramural Research Activities,
National Institute on Minority Health and
Health Disparities, National Institutes of
Health, Gateway Building, 7201 Wisconsin
Avenue, Bethesda, MD 20892, (301) 480–
4727, karen.nieveslugo@nih.gov.
Dated: September 17, 2021.
David W. Freeman,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2021–20583 Filed 9–22–21; 8:45 am]
BILLING CODE 4140–01–P
[FR Doc. 2021–20601 Filed 9–22–21; 8:45 am]
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
BILLING CODE 4165–15–P
National Institute on Minority Health
and Health Disparities; Notice of
Closed Meeting
lotter on DSK11XQN23PROD with NOTICES1
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Minority Health and Health Disparities
Special Emphasis Panel; Impact of Structural
Racism and Discrimination on Minority
Health and Health Disparities.
Date: November 15–17, 2021.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Gateway Plaza, 7201 Wisconsin Avenue,
Bethesda, MD 20817 (Virtual Meeting).
17:19 Sep 22, 2021
Jkt 253001
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; Exploratory Data Science
Methods and Algorithm Development, EarlyStage Development of Data Science
Technologies, and Enhancement or
Sustainment of Data Science Tools for
Infectious and Immune-Mediated Diseases
(R21, U01, U24).
Date: October 26–28, 2021.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute of Allergy and
Infectious Diseases, National Institutes of
PO 00000
Frm 00044
Fmt 4703
Sfmt 4703
2,310: Total hours spent on responses for all funded organizations over a 2-year period.
2,310.
Health, 5601 Fishers Lane, Room 3G42,
Rockville, MD 20892 (Virtual Meeting).
Contact Person: Sandip Bhattacharyya,
Ph.D., Scientific Review Officer, Scientific
Review Program, Division of Extramural
Activities, National Institute of Allergy and
Infectious Diseases, National Institutes of
Health, 5601 Fishers Lane, Room 3G42,
Rockville, MD 20852, 240–292–0189,
sandip.bhattacharyya@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: September 17, 2021.
Tyeshia M. Roberson-Curtis,
Program Analyst, Office of Federal Advisory
Committee Policy.
BILLING CODE 4140–01–P
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
National Institutes of Health
Total burden hours
[FR Doc. 2021–20585 Filed 9–22–21; 8:45 am]
National Institutes of Health
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
VerDate Sep<11>2014
Average
burden per
response
(in hours)
Number of respondents
Form name
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Neurological
Disorders and Stroke; Notice of Closed
Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of
meetings of the Board of Scientific
Counselors, National Institute of
Neurological Disorders and Stroke.
The meetings will be closed to the
public as indicated below in accordance
with the provisions set forth in section
552b(c)(6), Title 5 U.S.C., as amended
for the review, discussion, and
evaluation of individual intramural
programs and projects conducted by the
NATIONAL INSTITUTE OF
NEUROLOGICAL DISORDERS AND
STROKE, including consideration of
personnel qualifications and
performance, and the competence of
individual investigators, the disclosure
of which would constitute a clearly
unwarranted invasion of personal
privacy.
Name of Committee: Board of Scientific
Counselors, National Institute of
Neurological Disorders and Stroke.
E:\FR\FM\23SEN1.SGM
23SEN1
52916
Federal Register / Vol. 86, No. 182 / Thursday, September 23, 2021 / Notices
Date: October 24–26, 2021.
Time: 12:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate personnel
qualifications and performance, and
competence of individual investigators.
Place: Porter Neuroscience Research
Center, Building 35A, 35 Convent Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Nina F. Schor, MD, Ph.D.,
Deputy Director, National Institute of
Neurological Disorders and Stroke, NIH,
Building 31, Room 8A52, Bethesda, MD
20892, 301–496–9746, nina.schor@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.853, Clinical Research
Related to Neurological Disorders; 93.854,
Biological Basis Research in the
Neurosciences, National Institutes of Health,
HHS)
Dated: September 17, 2021.
Tyeshia M. Roberson-Curtis,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2021–20580 Filed 9–22–21; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Heart, Lung, and Blood
Institute; Notice of Meeting
lotter on DSK11XQN23PROD with NOTICES1
Pursuant to section 10(a) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the National Heart, Lung,
and Blood Advisory Council.
The meeting will be open to the
public, with attendance limited to space
available. Individuals who plan to
attend and need special assistance, such
as sign language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
Name of Committee: National Heart, Lung,
and Blood Advisory Council.
Date: October 26, 2021.
Closed: 10:00 a.m. to 11:00 a.m.
Agenda: To Review and Evaluate Grant
Applications.
Place: National Institutes of Health,
Rockledge 1, 6705 Rockledge Dr., Bethesda,
MD 20892 (Virtual Meeting).
Open: 11:30 a.m. to 5:00 p.m.
Agenda: To Discuss Program Policies and
Issues.
Place: National Institutes of Health,
Rockledge 1,6705 Rockledge Dr., Bethesda,
MD 20892 (Virtual Meeting).
Virtual Access: The meeting will be
videocast and can be accessed from the NIH
Videocast. https://www.nhlbi.nih.gov/about/
advisory-and-peer-review-committees/
advisory-council. Please note, the link to the
videocast meeting will be posted within a
week of the meeting date.
Contact Person: Laura K. Moen, Ph.D.,
Director, Division of Extramural Research
Activities, National Heart, Lung, and Blood
VerDate Sep<11>2014
17:19 Sep 22, 2021
Jkt 253001
Institute, National Institutes of Health, 6705
Rockledge Drive, Room 206–Q, Bethesda, MD
20892, 301–827–5517, moenl@mail.nih.gov
Any member of the public interested in
presenting oral comments to the committee
may notify the Contact Person listed on this
notice at least 10 days in advance of the
meeting. Interested individuals and
representatives of organizations may submit
a letter of intent, a brief description of the
organization represented, and a short
description of the oral presentation. Only one
representative of an organization may be
allowed to present oral comments and if
accepted by the committee, presentations
may be limited to five minutes. Both printed
and electronic copies are requested for the
record. In addition, any interested person
may file written comments with the
committee by forwarding their statement to
the Contact Person listed on this notice. The
statement should include the name, address,
telephone number and when applicable, the
business or professional affiliation of the
interested person.
Information is also available on the
Institute’s/Center’s home page:
www.nhlbi.nih.gov/meetings/nhlbac/
index.htm, where an agenda and any
additional information for the meeting will
be posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.233, National Center for
Sleep Disorders Research; 93.837, Heart and
Vascular Diseases Research; 93.838, Lung
Diseases Research; 93.839, Blood Diseases
and Resources Research, National Institutes
of Health, HHS)
Dated: September 17, 2021.
David W. Freeman,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2021–20584 Filed 9–22–21; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Center for Advancing
Translational Sciences; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
PO 00000
Frm 00045
Fmt 4703
Sfmt 4703
Name of Committee: National Center for
Advancing Translational Sciences Special
Emphasis Panel; SEP Limited Competition:
Clinical and Translational Science Award
(CTSA) Consortium-Wide Centers: Resources
for Rapid Demonstration and Dissemination
(U24 Clinical Trials Not Allowed).
Date: October 20, 2021.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Center for Advancing
Translational Sciences, National Institutes of
Health, 6701 Democracy Boulevard, Room
1037, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Victor Henriquez, Ph.D.,
Scientific Review Officer, Office of Scientific
Review, National Center for Advancing
Translational Sciences, National Institutes of
Health, 6701 Democracy Boulevard, Room
1037, Bethesda, MD 20817, (301) 435–0813,
henriquv@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.859, Pharmacology,
Physiology, and Biological Chemistry
Research; 93.350, B—Cooperative
Agreements; 93.859, Biomedical Research
and Research Training, National Institutes of
Health, HHS)
Dated: September 17, 2021.
David W. Freeman,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2021–20582 Filed 9–22–21; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Drug Abuse;
Notice of Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel;
Exploratory Studies to Investigate
Mechanisms of HIV Infection, Replication,
Latency, and/or Pathogenesis in the Context
of Substance Use Disorders (R61/R33—
Clinical Trial Not Allowed).
Date: October 26, 2021.
Time: 11:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
E:\FR\FM\23SEN1.SGM
23SEN1
]]>Agencies
[Federal Register Volume 86, Number 182 (Thursday, September 23, 2021)]
[Notices]
[Pages 52915-52916]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-20580]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Neurological Disorders and Stroke; Notice
of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of meetings of the Board of Scientific
Counselors, National Institute of Neurological Disorders and Stroke.
The meetings will be closed to the public as indicated below in
accordance with the provisions set forth in section 552b(c)(6), Title 5
U.S.C., as amended for the review, discussion, and evaluation of
individual intramural programs and projects conducted by the NATIONAL
INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE, including consideration
of personnel qualifications and performance, and the competence of
individual investigators, the disclosure of which would constitute a
clearly unwarranted invasion of personal privacy.
Name of Committee: Board of Scientific Counselors, National
Institute of Neurological Disorders and Stroke.
[[Page 52916]]
Date: October 24-26, 2021.
Time: 12:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate personnel qualifications and
performance, and competence of individual investigators.
Place: Porter Neuroscience Research Center, Building 35A, 35
Convent Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Nina F. Schor, MD, Ph.D., Deputy Director,
National Institute of Neurological Disorders and Stroke, NIH,
Building 31, Room 8A52, Bethesda, MD 20892, 301-496-9746,
[email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.853,
Clinical Research Related to Neurological Disorders; 93.854,
Biological Basis Research in the Neurosciences, National Institutes
of Health, HHS)
Dated: September 17, 2021.
Tyeshia M. Roberson-Curtis,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2021-20580 Filed 9-22-21; 8:45 am]
BILLING CODE 4140-01-P
